The World Health Organization’s newly released filovirus disease management guidelines contain 16 evidence-based clinical recommendations, establishing a comprehensive framework for managing all Ebola virus species and Marburg virus. This represents the first consolidated clinical approach addressing the full spectrum of filovirus pathogens.
Among these recommendations, early supportive care emerges as the critical intervention for improving patient survival and clinical outcomes. Rather than relying on antivirals alone, the guidelines emphasize comprehensive supportive management as the foundation of effective filovirus treatment across all species.
The guidelines’ release during the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo demonstrates the practical urgency of standardized clinical protocols. By consolidating recommendations previously scattered across separate filovirus species, WHO enables more efficient knowledge translation and faster clinical implementation in outbreak response scenarios.
Was this article helpful?
